#CDMO_Services
LightNews LightNews
newsen.bsky.social
Porton Advanced Solutions Receives Key Drug Manufacturing License to Enhance CDMO Services#China#Suzhou#CDMO_Services#Porton_Advanced#Drug_Manufacturing
Porton Advanced Solutions Receives Key Drug Manufacturing License to Enhance CDMO Services
Porton Advanced Solutions Ltd. has secured a Class C Drug Manufacturing License in China, enabling enhanced services in cell and gene therapy manufacturing.
third-news.com
August 5, 2026 at 11:45 AM
newsen.bsky.social
LTS Expands Capability to Deliver Ophthalmic Drug Solutions through CDMO Services#USA#Lakewood#CDMO_Services#LTS_Lohmann#Ophthalmic_Drug_Delivery
LTS Expands Capability to Deliver Ophthalmic Drug Solutions through CDMO Services
LTS Lohmann Therapie-Systeme AG broadens its portfolio by introducing CDMO services focused on ophthalmic drug delivery systems, enhancing sterile product manufacturing.
third-news.com
April 29, 2026 at 11:10 AM
newsen.bsky.social
Unlocking Biomanufacturing Flexibility for Rapid Scaling and Supply Resilience in Upcoming Webinar#Canada#Toronto#Biomanufacturing#CDMO_Services#Xtalks
Unlocking Biomanufacturing Flexibility for Rapid Scaling and Supply Resilience in Upcoming Webinar
Join an informative webinar on biomanufacturing strategies that expedite development timelines, minimize supply risks, and enhance product resilience.
third-news.com
March 10, 2026 at 1:00 PM
newsen.bsky.social
Scinai Immunotherapeutics Shares Strong Nine-Month 2025 Performance as CDMO Services Thrive#Scinai_Immunotherapeutics#Israel#Jerusalem#CDMO_Services#NanoAbs
Scinai Immunotherapeutics Shares Strong Nine-Month 2025 Performance as CDMO Services Thrive
Scinai Immunotherapeutics has reported impressive financial results for the first nine months of 2025, showcasing growth in CDMO services and advancing its innovative NanoAbs pipeline.
third-news.com
December 2, 2025 at 2:54 PM
newsen.bsky.social
Elevaris Unveils New CDMO Services and Needle Range at COMPAMED 2025#Germany#Medical_Devices#Düsseldorf#CDMO_Services#Elevaris
Elevaris Unveils New CDMO Services and Needle Range at COMPAMED 2025
Elevaris Medical Devices is set to introduce its contract development and manufacturing services along with an extensive needle portfolio at COMPAMED 2025 in Düsseldorf, Germany.
third-news.com
November 4, 2025 at 9:19 AM
newsen.bsky.social
Elevaris Medical Devices Launches CDMO Services and Procedural Needles in EMEA#USA#Boston#CDMO_Services#Elevaris_Medical#Procedural_Needles
Elevaris Medical Devices Launches CDMO Services and Procedural Needles in EMEA
Elevaris Medical Devices makes its debut at COMPAMED, showcasing its CDMO services and a range of procedural needles in the EMEA region.
third-news.com
November 4, 2025 at 9:18 AM
newsen.bsky.social
Elevaris Expands its Reach with CDMO Services and Needle Portfolio in EMEA#None#Düsseldorf#CDMO_Services#Elevaris_Medical#Procedural_Needles
Elevaris Expands its Reach with CDMO Services and Needle Portfolio in EMEA
Elevaris Medical Devices has introduced its CDMO services and specialized procedural needles in the EMEA region. Discover their innovative capabilities at COMPAMED.
third-news.com
November 4, 2025 at 9:18 AM
newsen.bsky.social
Scinai Immunotherapeutics Sees Financial Growth in 2025 with Enhanced CDMO Revenue#None#Scinai_Immunotherapeutics#biopharmaceuticals#CDMO_Services
Scinai Immunotherapeutics Sees Financial Growth in 2025 with Enhanced CDMO Revenue
Scinai Immunotherapeutics reports significant financial growth in H1 2025, with CDMO revenue increasing and a strengthened balance sheet.
third-news.com
September 2, 2025 at 11:38 AM
newsen.bsky.social
MedEdge Innovations Launches Advanced ePTFE Platform and CDMO Services for Medical Devices#China#Suzhou#CDMO_Services#MedEdge_Innovations#ePTFE
MedEdge Innovations Launches Advanced ePTFE Platform and CDMO Services for Medical Devices
MedEdge Innovations introduces a new ePTFE platform along with customized CDMO services designed for medical implant applications, ensuring high performance and reliability for device manufacturers.
third-news.com
July 1, 2025 at 12:39 PM
newsen.bsky.social
Scinai Unveils New Funding and Promotes CDMO Expansion During Upcoming BIO International Convention 2025#Scinai_Immunotherapeutics#Israel#Jerusalem#CDMO_Services#BIO_Convention_2025
Scinai Unveils New Funding and Promotes CDMO Expansion During Upcoming BIO International Convention 2025
Scinai Immunotherapeutics announces exciting funding achievements and growth in its CDMO services, setting the stage for the BIO International Convention 2025.
third-news.com
June 12, 2025 at 12:23 PM
newsen.bsky.social
Scinai Immunotherapeutics to Present Cutting-Edge Innovations at BIO-Europe Spring 2025#Scinai_Immunotherapeutics#Israel#Jerusalem#CDMO_Services#NanoAbs
Scinai Immunotherapeutics to Present Cutting-Edge Innovations at BIO-Europe Spring 2025
Scinai Immunotherapeutics will showcase its advanced inflammation and immunology pipeline during BIO-Europe Spring 2025 in Milan, enhancing visibility and investor engagement.
third-news.com
March 17, 2025 at 11:14 AM
newsen.bsky.social
Scinai Immunotherapeutics Prepares for Major US Conferences to Connect with Industry Leaders#USA#Scinai_Immunotherapeutics#CDMO_Services#NanoAbs#Miami,_San_Francisco
Scinai Immunotherapeutics Prepares for Major US Conferences to Connect with Industry Leaders
Scinai Immunotherapeutics is set to engage with investors and pharma leaders at major upcoming US conferences. Key executives will seek strategic partnerships and showcase their innovative nanoAbs.
third-news.com
January 6, 2025 at 12:43 PM